Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
08/03/2000 | WO2000044915A1 Method for conveying bnyvv resistance to sugar beet plants |
08/03/2000 | WO2000044908A2 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins |
08/03/2000 | WO2000044906A2 GENES IDENTIFIED AS REQUIRED FOR PROLIFERATION IN $i(ESCHERICHIA COLI) |
08/03/2000 | WO2000044905A1 Slow growing acid-fast bacterium polypeptide |
08/03/2000 | WO2000044904A1 Basb059 polypeptides from neisseria meningitidis |
08/03/2000 | WO2000044903A1 Platelet-derived growth factor/vascular endothelial growth factor-like growth factor h, and uses thereof |
08/03/2000 | WO2000044902A2 Biomarkers and assays for carcinogenesis induced by phenobarbitol |
08/03/2000 | WO2000044901A1 Transcriptional regulation of the human beta3-adrenergic receptor gene |
08/03/2000 | WO2000044900A2 Nucleic-acid binding proteins |
08/03/2000 | WO2000044899A1 Her-2/neu fusion proteins |
08/03/2000 | WO2000044898A2 Novel agouti and agouti-related peptide analogs |
08/03/2000 | WO2000044894A1 Method for isolating apoptosis-inducing dna sequences and detection system |
08/03/2000 | WO2000044892A1 Controlled expression of heterologous proteins in the mammary gland of a transgenic animal |
08/03/2000 | WO2000044890A1 Immunogenic compounds |
08/03/2000 | WO2000044889A2 Mammal with inducible ductal carcinoma in situ |
08/03/2000 | WO2000044886A1 PROCESS FOR PRODUCING HMG-CoA REDUCTASE INHIBITOR |
08/03/2000 | WO2000044884A1 Bhv-1 gene-deleted virus vaccine |
08/03/2000 | WO2000044879A1 Aggressive prostate cancer sublines selected by androgen deprivation |
08/03/2000 | WO2000044878A1 Compartmentalization of recombinant polypeptides in host cells |
08/03/2000 | WO2000044787A1 Nucleic acid encoding bovine calcitonin receptor-like receptor |
08/03/2000 | WO2000044786A1 Novel potassium channels and genes encoding these potassium channels |
08/03/2000 | WO2000044785A1 Gcsf conjugates |
08/03/2000 | WO2000044784A1 Nucleic acid and amino acid sequences |
08/03/2000 | WO2000044783A1 Meg-4 protein |
08/03/2000 | WO2000044782A2 Ewing's tumour antigen, nucleic acid and antibodies |
08/03/2000 | WO2000044781A1 Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin |
08/03/2000 | WO2000044780A1 Polypeptide capable of binding to mannose and uses therefor |
08/03/2000 | WO2000044776A1 Alpha-conotoxin peptides |
08/03/2000 | WO2000044775A2 Identification of broadly reactive hla restricted t cell epitopes |
08/03/2000 | WO2000044773A1 STAPHYLOCOCCUS AUREUS fabG |
08/03/2000 | WO2000044772A2 Human serum albumin |
08/03/2000 | WO2000044771A1 Transcription factor e2f dna-binding domain inhibitor peptides and their use |
08/03/2000 | WO2000044769A1 Conotoxin peptides |
08/03/2000 | WO2000044767A2 Method for drying protein crystals |
08/03/2000 | WO2000044766A1 Inhibition of cationic amino acid transporter protein and uses thereof |
08/03/2000 | WO2000044765A1 Mvk |
08/03/2000 | WO2000044764A1 Mvd |
08/03/2000 | WO2000044413A1 Methods and compositions for healing and repair of articular cartilage |
08/03/2000 | WO2000044406A2 Dna vaccines against hantavirus infections |
08/03/2000 | WO2000044404A2 Methods for inhibiting brain tumor growth by using selected integrin antagonists |
08/03/2000 | WO2000044403A1 Her-2 binding antagonists |
08/03/2000 | WO2000044401A1 Use of a melanoma inhibiting activity factor (mia) for cartilage and bone repair |
08/03/2000 | WO2000044400A1 Treatment for diabetes |
08/03/2000 | WO2000044399A2 Treatment of erectile dysfunctions with a c-type natriuretic polypeptide (cnp) as monotherapy or in combination with phosphodiesterase inhibitors |
08/03/2000 | WO2000044395A1 Methods and compositions for modulating fertility |
08/03/2000 | WO2000044394A1 Method of producing elastin, elastin-based materials and tropoelastin materials |
08/03/2000 | WO2000044392A2 Identification of specific differentially expressed mycobacterial antigens |
08/03/2000 | WO2000032175A3 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY |
08/03/2000 | WO2000028061A3 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
08/03/2000 | WO2000028052A3 Nucleic acid molecules from rice encoding an r1 protein and their use for the production of modified starch |
08/03/2000 | WO2000027881A3 Human interleukin 10 mutant proteins |
08/03/2000 | WO2000027874A3 Nucleic acids encoding transferrin receptor-like proteins and products related thereto |
08/03/2000 | WO2000026388A3 Novel expression cassette for expressing genes in plant seed |
08/03/2000 | WO2000026238A3 Biological materials and methods useful in the diagnosis and treatment of prion diseases |
08/03/2000 | WO2000024412A3 Use of vegf-c or vegf-d gene or protein to prevent restenosis |
08/03/2000 | WO2000023587A3 Gene therapy of alzheimer's disease by delivery of an encoded apolipoprotein e |
08/03/2000 | WO2000023471A3 Use of a cytokine-producing lactococcus strain to treat colitis |
08/03/2000 | WO2000022137A3 Selectively replicating viral vectors |
08/03/2000 | WO2000021985A3 Genes encoding olfactory receptors and biallelic markers thereof |
08/03/2000 | WO2000021984A3 Nucleic acids encoding human cide-b protein and polymorphic markers thereof |
08/03/2000 | WO2000020835A3 Thromboplastin reagents and methods for preparing and using such reagents |
08/03/2000 | WO2000020609A3 Protective recombinant haemophilus influenzae high molecular weight proteins |
08/03/2000 | WO2000018921A3 Synthetic peptides having fgf receptor affinity |
08/03/2000 | WO2000014240A3 Attenuated salmonella sp12 mutants as antigen carriers |
08/03/2000 | WO2000010593A9 USE OF mCRP TO SLOW CELL GROWTH AND TO PROMOTE MATURATION OF CELLS |
08/03/2000 | WO2000009691A9 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
08/03/2000 | WO2000009689A9 A single gene encoding aortic-specific and striated-specific muscle cell isoforms, its regulatory sequences and uses thereof |
08/03/2000 | WO2000009551A9 Human chordin-related proteins and polynucleotides encoding them |
08/03/2000 | WO2000009550A9 Vanadate resistance glycosylation 4 gene |
08/03/2000 | WO2000009549A9 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
08/03/2000 | WO2000009074A9 Variable output applicator and method for multi-component biologic fluid agents, and application method |
08/03/2000 | WO2000009018A9 Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing |
08/03/2000 | WO2000008174A9 β-CASEIN EXPRESSING CONSTRUCTS |
08/03/2000 | WO2000008131A9 Pseudotyped retroviruses and stable cell lines for their production |
08/03/2000 | WO2000008051A3 Immunological herpes simplex virus antigens and methods for use thereof |
08/03/2000 | WO2000008050A9 Dna encoding human monocyte-macrophage apolipoprotein b receptor gene and protein |
08/03/2000 | WO2000006731A3 Persephin arf, a protein encoded by unspliced persephin mrna |
08/03/2000 | WO2000006589A9 Prostate derived ets factor |
08/03/2000 | WO2000006185A3 Methods of using lanreotide, a somatostatin analogue |
08/03/2000 | WO2000005262A9 Uses of igf-i e domain peptides |
08/03/2000 | WO2000001823A3 Flt3-l mutants and methods of use |
08/03/2000 | WO2000000617A9 Ebola virion proteins expressed from venezuelan equine encephalitis (vee) virus replicons |
08/03/2000 | WO1999062941A8 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
08/03/2000 | WO1999062561A3 Gene therapy method |
08/03/2000 | WO1999057132A8 Secreted proteins and polynucleotides encoding them |
08/03/2000 | WO1999055366A8 Chimeras of hepatitis c virus and bovine viral diarrhea virus |
08/03/2000 | WO1998017782A8 Method for producing transgenic animal models with modulated phenotype and animals produced therefrom |
08/03/2000 | DE19950385A1 Verfahren zur Isolation von Apoptose-induzierenden DNA-Sequenzen und Detektionssystem A process for the isolation of apoptosis-inducing DNA sequences and detection system |
08/03/2000 | DE19903495A1 Ewing-Tumor-Antigen und Nukleinsäure Ewing's tumor antigen and nucleic acid |
08/03/2000 | DE19903345A1 Kompartimentierung von rekombinanten Polypeptiden in Wirtszellen Compartmentalization of recombinant polypeptides in host cells |
08/03/2000 | CA2743116A1 Alpha-conotoxin peptides with a 4/7 motif |
08/03/2000 | CA2368214A1 Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin |
08/03/2000 | CA2363565A1 Basb059 polypeptides from neisseria meningitidis |
08/03/2000 | CA2361271A1 Methods and compositions for modulating fertility |
08/03/2000 | CA2361246A1 Identification of specific differentially expressed antigens |
08/03/2000 | CA2361239A1 Treatment of erectile dysfunctions with a c-type natriuretic polypeptide (cnp) as monotherapy or in combination with phosphodiesterase inhibitors |
08/03/2000 | CA2360374A1 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins |
08/03/2000 | CA2360146A1 Methods for inhibiting brain tumor growth by using selected integrin antagonists |
08/03/2000 | CA2360085A1 Genes identified as required for proliferation in escherichia coli |
08/03/2000 | CA2360084A1 Immunogenic compounds |